All data are based on the daily closing price as of November 11, 2026
l

L&C Bio

290650.KQ
16.89 USD
-0.15
-0.88%

Overview

Last close
16.89 usd
Market cap
1.03B usd
52 week high
81.75 usd
52 week low
16.05 usd
Target price
26.97 usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
11.8814
Price/Book Value
4.2268
Enterprise Value
1.04B usd
EV/Revenue
11.9941
EV/EBITDA
8.8241

Key financials

Revenue TTM
87.12M usd
Gross Profit TTM
51.11M usd
EBITDA TTM
20.54M usd
Earnings per Share
-1.85 usd
Dividend
0.02 usd
Total assets
308.51M usd
Net debt
14.34M usd

About

L&C BIO Co.,LTD operates as a research and development company in tissue regeneration medicine. The company offers pharmaceuticals, human tissue, medical device, and cosmetics products. L&C BIO Co.,LTD was founded in 2011 and is headquartered in Seongnam-si, South Korea.
  • Symbol
    290650.KQ
  • Exchange
    KQ
  • Isin
    KR7290650001
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Medical Devices
  • CEO
    Mr. Chul Lee Whan
  • Headquarter
    Seongnam-si
  • Web site
    https://www.lncbio.co.kr
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top